Cat. No. BRC0422
|It belongs to next groups of Bioreference compounds:|
Ticlopidine is a prodrug that is metabolised to an as yet undetermined metabolite that acts as a platelet aggregation inhibitor. Inhibition of platelet aggregation causes a prolongation of bleeding time. In its prodrug form, ticlopidine has no significant in vitro activity at the concentrations attained in vivo.
|Targets:||P2Y purinoceptor 12|
1.Br. J. Pharmacol. 2010; 161(5), 1150 - 1160.; 2.Eur. J. Pharmacol. 2004; 484(1), 19 - 27.;